期刊文献+

乌苯美司口腔崩解片的研制 被引量:2

Study on Ubenimex Orally Disintegrating Tablets
下载PDF
导出
摘要 目的探讨乌苯美司口腔崩解片的制备工艺,优化最佳处方;检测片剂的溶出度.方法以崩解时限为主要指标,通过单因素试验及正交试验设计优化乌苯美司口腔崩解片的最佳制备工艺;利用溶出仪(稍作改良)检测法检测口腔崩解片的溶出度.结果MCC∶L-HPC∶CMC-Na(9∶1∶0.75)作为崩解剂,湿法制粒压片制得的乌苯美司口腔崩解片,体外平均崩解时限为21 s,置于口腔内25 s即可崩解,无砂砾感;片剂体外溶出度10 min溶出基本完全.结论乌苯美司口腔崩解片于口腔内可迅速崩解,制备工艺简单,有效改善了药物粉末的流动性,适宜于生产. The purpose of this paper is to discuss the prepared technique of Ubenimex orally disintegrating tablets and select the best prescription. The formulation of orally disintegrating tablet is optimized by single factor and orthogonal tests; the dissolution rates are examined by the dissolution instrument. RESULTS MCC, L-HPC and CMC-Na(9 : 1: 0. 75)are chosen as disintegrants and the Ubenmimex orally disintegrating tablets are compressed by wetting granulating method. The mean time for complete disintegration is 21 seconds and the disintegrating time in oral cavity is within 25 seconds without any residuary rough granules,and the invitrodissolution test indicates that 100% of Ubenmimex dissolves in 10 minutes. The results show that the prepared Ubenimex orally disintegrating tablet can disintegrate rapidly in oral cavity without any residuary rough granules,and the process of preparation is feasible due to the improvent of the flow property of powders by using the wetting granulating method.
出处 《湖南工程学院学报(自然科学版)》 2009年第2期61-63,共3页 Journal of Hunan Institute of Engineering(Natural Science Edition)
关键词 口腔崩解片 乌苯美司 处方筛选 崩解时限 溶出度 orally disintegrating tablet Ubenimex formulation optimization disintegration dissolution rates
  • 相关文献

参考文献6

二级参考文献22

  • 1Panyathip,朱家壁,陈盛君,陈永玲.聚维酮碘口腔速崩片的研制[J].中国医药工业杂志,2004,35(9):534-536. 被引量:10
  • 2张艳红,张茂森.新型口服速溶制剂──冻干速溶片[J].国外医学(药学分册),1996,23(4):202-206. 被引量:15
  • 3.中国药典2000年版:二部[S].,2000.附录64-65.
  • 4Yunxia Bi, Sunada H, Yonezawa Y, et al. Preparation and evalution of a compressed tablet rapidly disintegrating in the oral cavity[J]. Chem Pharm Bull, 1996,44 ( 11 ) :2121-2127.
  • 5BI YX, SUNADA H, YONEZAWA Y, et al. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity [J]. Chem Pharm Bull , 1996, 44(11) : 2121.
  • 6WATANABE Y, KOIZUMI K, ZAMA Y, et al. New Compressed tablet disintegrating in saliva in saliva in the mouth using crystalline cellulose and a disintegrate [ J]. Biol Pharm Bull, 1995,18(9) :1308-1310.
  • 7FERERRO C,.MUNOZ N,VELASCO A, et al. Disintegrating efficiency of croscarm ellose sodium in a direct compression formulation[J]. Int J Pharm, 1997, 147 (1): 11-12.
  • 8SUGIMOTO M, MATSUBARA K, KOIDA Y, et al. The preparation of rapidly disintegrating tablets in the mouth [ J]. Pharm Dev Technol, 2001, 6(4) :487 -493.
  • 9ISHIKAWA T, WATANABE Y, UTOGUCHI N, et al. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method[J]. Chem Pharm Bull (Tokyo) , 1999,47(10) :1451 - 1454.
  • 10KOIZUMI K, WATANABE Y, MORITA K, New method of preparing high-porosity saliva soluble compressed tablets using mannitol with camphor,a subliming material[J]. Int J Pharm,1997,152(1) :127 - 131.

共引文献36

同被引文献6

  • 1日本药局方[S].第16版.2011.545-546.
  • 2に準拠して作成.日本病院薬剤師会のIF記載要領(1998年9月).2005,4.
  • 3Umezawa H, Aoyagl T, Suda H, et al. Bestatin, an inhibitor ofaminopeptidase B, produced by actinomycetes [ J ]. Antibiotics, 1976, (29) :97-101.
  • 4国家食品药品监督管理局标准YBH05722010[S].
  • 5国家食品药品监督管理局标准YBH07102009[S].
  • 6周善学,艾林.乌苯美司应用研究进展[J].国外医药(抗生素分册),1997,18(4):304-307. 被引量:3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部